Quantitative assessment of heteroplasmy of mitochondrial genome: Perspectives in diagnostics and methodological pitfalls

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Sobenin, Igor A ^a,b   Mitrofanov, Konstantin Y ^b   Zhelankin, Andrey V ^a,b   Sazonova, Margarita A ^a,b   Postnov, Anton Y ^a   Revin, Victor V ^c   Bobryshev, Yuri V ^c,d,e   Orekhov, Alexander N ^b,f  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c OGAREV MORDOVIA STATE UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF WESTERN SYDNEY   (Australia)

^f Skolkovo Innovative Centre   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; MITOCHONDRIAL DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CHRONIC DISEASE; COMPARATIVE STUDY; DNA HYBRIDIZATION; DNA POLYMORPHISM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROPLASMY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; METHODOLOGY; MITOCHONDRIAL GENOME; MOLECULAR DIAGNOSIS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE ANALYSIS; ANIMAL; GENETICS; MITOCHONDRIAL DISEASES; MUTATION; PROCEDURES;

ANIMALS; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; GENOME, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; MUTATION;

EID: 84900008808     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/292017     Document Type: Review

References (39)

1. Boesch P., Weber-Lotfi F., Ibrahim N., Tarasenko V., Cosset A., Paulus F., Lightowlers R. N., Dietrich A., DNA repair in organelles: pathways, organization, regulation, relevance in disease and aging. Biochimica et Biophysica Acta 2011 1813 1 186 200 2-s2.0-78650744276 10.1016/j.bbamcr.2010.10. 002
2. Haag-Liautard C., Coffey N., Houle D., Lynch M., Charlesworth B., Keightley P. D., Direct estimation of the mitochondrial DNA mutation rate in Drosophila melanogaster. PLoS Biology 2008 6 8 e204 2-s2.0-53549124410 10.1371/journal.pbio.0060204
3. van den Ouweland J. M. W., Lemkes H. H. P. J., Ruitenbeek W., Sandkuijl L. A., De Vijlder M. F., Struyvenberg P. A. A., Van De Kamp J. J. P., Maassen J. A., Mutation in mitochondrial tRMALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genetics 1992 1 5 368 371 2-s2.0-0026906885
4. Majamaa-Voltti K., Peuhkurinen K., Kortelainen M.-L., Hassinen I. E., Majamaa K., Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovascular Disorders 2002 2, article 12 2-s2.0-0141971998 10.1186/1471-2261-2-12
5. Sazonova M., Budnikov E., Khasanova Z., Sobenin I., Postnov A., Orehov A., Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 2009 204 1 184 190 2-s2.0-67349183319 10.1016/j.atherosclerosis.2008.09.001
6. Zhang S., Tong A.-L., Zhang Y., Nie M., Li Y.-X., Wang H., Heteroplasmy level of the mitochondrial tRNALeu(UUR) A3243G mutation in a chinese family is positively associated with earlier age-of-onset and increasing severity of diabetes. Chinese Medical Sciences Journal 2009 24 1 20 25 2-s2.0-64949105223 10.1016/S1001-9294(09)60053-5
7. Irwin J. A., Saunier J. L., Niederstätter H., Strouss K. M., Sturk K. A., Diegoli T. M., Brandstätter A., Parson W., Parsons T. J., Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. Journal of Molecular Evolution 2009 68 5 516 527 2-s2.0-67349134670 10.1007/s00239-009-9227-4
8. Meierhofer D., Mayr J. A., Ebner S., Sperl W., Kofler B., Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 2005 5 4 282 296 2-s2.0-22544462198 10.1016/j.mito.2005.06.001
9. Cassandrini D., Calevo M. G., Tessa A., Manfredi G., Fattori F., Meschini M. C., Carrozzo R., Tonoli E., Pedemonte M., Minetti C., Zara F., Santorelli F. M., Bruno C., A new method for analysis of mitochondrial DNA point mutations and assess levels of heteroplasmy. Biochemical and Biophysical Research Communications 2006 342 2 387 393 2-s2.0-33344469159 10.1016/j.bbrc.2006.01.152
10. Dobrowolski S. F., Hendrickx A. T., van den Bosch B. J., Identifying sequence variants in the human mitochondrial genome using high-resolution melt (HRM) profiling. Human Mutation 2009 30 891 898
11. Wong L.-J. C., Chen T.-J., Tan D.-J., Detection of mitochondrial DNA mutations using temporal temperature gradient gel electrophoresis. Electrophoresis 2004 25 15 2602 2610 2-s2.0-4444308325 10.1002/elps.200406016
12. Mashima Y., Nagano M., Funayama T., Zhang Q., Egashira T., Kudho J., Shimizu N., Oguchi Y., Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the Invader technology. Clinical Biochemistry 2004 37 4 268 276 2-s2.0-1542346402 10.1016/j.clinbiochem.2003.11.011
13. Bai R.-K., Wong L.-J. C., Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clinical Chemistry 2004 50 6 996 1001 2-s2.0-2642539211 10.1373/clinchem.2004.031153
14. Bannwarth S., Procaccio V., Paquis-Flucklinger V., Surveyor nuclease: a new st rategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. Human Mutation 2005 25 6 575 582 2-s2.0-20344384545 10.1002/humu.20177
15. Zaragoza M. V., Fass J., Diegoli M., Lin D., Arbustini E., Mitochondrial DNA variant discovery and evaluation in human cardiomyopathies through next generation sequencing. PLoS ONE 2010 5 8 2-s2.0-77957925524 10.1371/journal. pone.0012295 e12295
16. Trifunovic A., Hansson A., Wredenberg A., Rovio A. T., Dufour E., Khvorostov I., Spelbrink J. N., Wibom R., Jacobs H. T., Larsson N.-G., Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proceedings of the National Academy of Sciences of the United States of America 2005 102 50 17993 17998 2-s2.0-29144458899 10.1073/pnas.0508886102
17. Edgar D., Trifunovic A., The mtDNA mutator mouse: dissecting mitochondrial involvement in aging. Aging 2009 1 12 1028 1032 2-s2.0-77953630947
18. Krishnan K. J., Reeve A. K., Samuels D. C., Chinnery P. F., Blackwood J. K., Taylor R. W., Wanrooij S., Spelbrink J. N., Lightowlers R. N., Turnbull D. M., What causes mitochondrial DNA deletions in human cells? Nature Genetics 2008 40 3 275 279 2-s2.0-39749124232 10.1038/ng.f.94
19. Chung I.-M., Schwartz S. M., Murry C. E., Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. The American Journal of Pathology 1998 152 4 913 923 2-s2.0-0031946472
20. Schwartz S. M., Murry C. E., Proliferation and the monoclonal origins of atherosclerotic lesions. Annual Review of Medicine 1998 49 437 460 2-s2.0-0031969967 10.1146/annurev.med.49.1.437
21. Andreeva E. R., Pugach I. M., Orekhov A. N., Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis 1997 130 133 142
22. Bogliolo M., Izzotti A., de Flora S., Carli C., Abbondandolo A., Degan P., Detection of the 4977 bp mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 1999 14 1 77 82 2-s2.0-0032935409 10.1093/mutage/14.1.77
23. Botto N., Berti S., Manfredi S., Al-Jabri A., Federici C., Clerico A., Ciofini E., Biagini A., Andreassi M. G., Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutation Research 2005 570 1 81 88 2-s2.0-13144294039 10.1016/j.mrfmmm.2004.10.003
24. Nomiyama T., Tanaka Y., Piao L., Hattori N., Uchino H., Watada H., Kawamori R., Ohta S., Accumulation of somatic mutation in mitochondrial DNA and atherosclerosis in diabetic patients. Annals of the New York Academy of Sciences 2004 1011 193 204 2-s2.0-2342485822 10.1196/annals.1293.020
25. Mueller E. E., Eder W., Ebner S., Schwaiger E., Santic D., Kreindl T., Stanger O., Paulweber B., Iglseder B., Oberkofler H., Maier R., Mayr J. A., Krempler F., Weitgasser R., Patsch W., Sperl W., Kofler B., The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS ONE 2011 6 1 2-s2.0-79551505787 10.1371/journal.pone. 0016455 e16455
26. Sobenin I. A., Sazonova M. A., Postnov A. Y., Bobryshev Y. V., Orekhov A. N., Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta. Clinical and Developmental Immunology 2012 2012 5 832464 10.1155/2012/832464
27. Sobenin I. A., Sazonova M. A., Postnov A. Y., Bobryshev Y. V., Orekhov A. N., Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease. Atherosclerosis 2013 227 283 288
28. Sobenin I. A., Sazonova M. A., Ivanova M. M., Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS ONE 2012 7 10 e46573
29. Sobenin I. A., Sazonova M. A., Postnov A. Y., Salonen J. T., Bobryshev Y. V., Orekhov A. N., Association of mitochondrial genetic variation with carotid atherosclerosis. PLoS ONE 2013 8 7 e68070
30. Moraes C. T., Ciacci F., Bonilla E., Jansen C., Hirano M., Rao N., Lovelace R. E., Rowland L. P., Schon E. A., DiMauro S., Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? Journal of Clinical Investigation 1993 92 6 2906 2915 2-s2.0-0027145131
31. Rossmanith W., Karwan R. M., Impairment of tRNA processing by point mutations in mitochondrial tRNALeu(UUR) associated with mitochondrial diseases. FEBS Letters 1998 433 3 269 274 2-s2.0-0032555354
32. Levinger L., Mörl M., Florentz C., Mitochondrial tRNA 3°and metabolism and human disease. Nucleic Acids Research 2004 32 18 5430 5441 2-s2.0-6044249065 10.1093/nar/gkh884
33. Sobenin I. A., Chistiakov D. A., Bobryshev Y. V., Postnov A. Y., Orekhov A. N., Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications. Current Pharmaceutical Design 2013 19 5942 5953
34. Wallace D. C., Mitochondria and cancer. Nature Reviews Cancer 2012 12 685 698
35. Yu M., Somatic mitochondrial DNA mutations in human cancers. Advances in Clinical Chemistry 2012 57 99 138 2-s2.0-84858819435 10.1016/B978-0-12-394384-2. 00004-8
36. Pereira L., Soares P., Máximo V., Samuels D. C., Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors. BMC Cancer 2012 12, article 53 2-s2.0-84856420412 10.1186/1471-2407-12-53
37. Naue J., Sänger T., Schmidt U., Klein R., Lutz-Bonengel S., Factors affecting the detection and quantification of mitochondrial point heteroplasmy using Sanger sequencing and SNaPshot minisequencing. International Journal of Legal Medicine 2011 125 3 427 436 2-s2.0-79956117062 10.1007/s00414-011-0549-6
38. Biffi S., Bortot B., Carrozzi M., Severini G. M., Quantification of heteroplasmic mitochondrial DNA mutations for DNA samples in the low picogram range by nested real-time ARMS-qPCR. Diagnostic Molecular Pathology 2011 20 2 117 122 2-s2.0-79958041835 10.1097/PDM.0b013e3181efe2c6
39. Chavakis T., Bierhaus A., Nawroth P. P., RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes and Infection 2004 6 13 1219 1225 2-s2.0-5644256969 10.1016/j.micinf.2004.08. 004